Simultaneous pancreas-kidney (SPK) transplantation remains the most effective treatment
for providing consistent and long-term euglycemia in patients having type 1 diabetes with …

Pancreatic transplantation is an established treatment for patients with type 1 diabetes
patients and select type 2 diabetes patients, with excellent survival rates as graft health is …

Complete graft thrombosis is the leading cause of early graft loss following pancreas
transplantation. Partial thrombosis is usually subclinical and discovered on routine imaging …

Background Complications leading to early technical failure have been the Achilles' heel of
simultaneous pancreas‐kidney transplantation (SPKT). The study purpose was to analyze …

Cryopreservation offers the potential to increase the availability of pancreatic islets for
treatment of diabetic patients. However, current protocols, which use dimethyl sulfoxide …

BACKGROUND Despite technical refinements, early pancreas graft loss due to thrombosis
continues to occur. Conventional coagulation tests (CCT) do not detect hypercoagulability …

Background. Graft thrombosis is the main cause of early graft loss following pancreas
transplantation, and is more frequent in pancreas transplant alone (PTA) compared with …

Simultaneous pancreas and kidney transplantation is the optimum treatment for patients with
type 1 diabetes and renal failure, providing survival benefit over deceased donor kidney …

Pancreas transplant achieves consistent long‐term euglycemia in type 1 diabetes. Allograft
thrombosis (AT) causes the majority of early graft failure. We compared outcomes of four …

Simultaneous pancreas-kidney transplantation is the treatment of choice for insulin-
dependent diabetes that associates end-stage diabetic nephropathy, since it achieves not …